Podcast Episodes
Back to Search
Episode: 49 - Building a Next Generation Bioproduction Platform
Season 3 Episode 49
Kyron.Bio is revolutionizing drug production with its Next Generation Bioproduction Platform that will make the production of therapeutics easier, ch…
3 years, 4 months ago
Episode: 48 - A Conversation with Peter Tessier: Classifying Antibodies to Assess Biologics Developability Features Early in the Discovery Process
Season 3 Episode 48
In this month’s episode of the Chain, guest Peter Tessier, Albert M. Mattocks pharmaceutical sciences and chemical engineering professor at the Unive…
3 years, 5 months ago
Episode: 47 - Bonus Episode with PEGS Young Scientist Keynote Dr. Andrew Anzalone on Engineering Prime Editor Proteins for Therapeutic Applications
Season 3 Episode 47
Dr. Andrew Anzalone, head of the Prime Editing Platform and scientific co-founder at Prime Medicine, is the winner of the PEGS Boston 2023 Young Scie…
3 years, 5 months ago
Episode: 46 - Leveraging Albumin and IgG FcRn-Mediated Regulation in Therapeutic Development
Season 3 Episode 46
Jan Terje Andersen, professor of biomedical innovation in the Department of Pharmacology at the University of Oslo and research group leader in the D…
3 years, 6 months ago
Episode: 45 - Advances in Targeted Protein Degradation
Season 3 Episode 45
In this month’s episode of the Chain, Jim Wells, professor of pharmaceutical chemistry and cellular and molecular pharmacology at the University of C…
3 years, 7 months ago
Episode 44: Structure Forward: Using Structural Biology Pipelines to Achieve Favorable Antibody Responses
Season 3 Episode 44
Over the last two decades, cryogenic electron microscopy (cryo-EM) has transformed from what Dr. Andrew Ward calls the “outcast of structural biology…
3 years, 8 months ago
Episode: 43 - Evolution of Antibody Technologies
Season 3 Episode 43
Dame Jane Osbourn, chief scientific officer at Alchemab Therapeutics, speaks with Ahuva Nissim, antibody and therapeutic engineering professor at Que…
3 years, 9 months ago
Episode: 42 - Machine Learning Informatics for Antibody Discovery
Season 3 Episode 42
Charlotte Deane, professor of structural bioinformatics at the University of Oxford and upcoming speaker at the 14th Annual PEGS Europe Conference in…
3 years, 10 months ago
Episode: 41 - Introduction and Evolution of the Antibody Patent Landscape
Season 3 Episode 41
After over 25 years as an intellectual property (IP) attorney, Jane Remillard, Nelson Mullins patents and biotechnology IP senior partner, is well-ve…
3 years, 11 months ago
Episode 40: Exploring Developability Concepts with Bispecific Antibodies
Season 2 Episode 40
Dr. Nimish Gera, Head of Biologics at Mythic Therapeutics, sits down with Christina Lingham, Executive Director of Conferences and Fellow at Cambridg…
4 years, 10 months ago